The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.
about
Analysis of Fascin-1 in Relation to Gleason Risk Classification and Nuclear ETS-Related Gene Status of Human Prostate Carcinomas: An Immunohistochemical Study of Clinically Annotated Tumours From the Wales Cancer Bank.Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.ERG rearrangement as a novel marker for predicting the extra-prostatic extension of clinically localised prostate cancer.Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a reviewProstate cancer in Jordanian-Arab population: ERG status and relationship with clinicopathologic characteristics.Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.ERG expression in prostate cancer: the prognostic paradox.Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the LiteratureSystematic analysis reveals molecular characteristics of ERG-negative prostate cancer
P2860
Q33459386-CD1B71F6-F0C3-4941-899B-559CEE3569DCQ35690915-658F0E8A-88B3-47A6-9868-26EB03F6831EQ36741911-246F0328-001D-4094-B13B-8374FCF59380Q37156611-96A26837-F39D-4B78-950B-2ABE991A5692Q38253055-35CC44E4-CE62-44E2-B450-CD3A828EA4E3Q38760532-EB0E1F7C-C7BC-4669-8DBE-C2B507C9C37BQ38983831-3C481635-7453-4930-AABA-11143E87EB8FQ39117370-595530C1-DF92-42F9-83ED-65204804C292Q40908009-462F227B-F76E-4435-9F20-D1BDED0CB0F9Q43141644-655EDDF3-8C43-4238-832F-E691E264ED4DQ46522843-AF7C6C16-5E0B-44F3-B217-6A10229EDB13Q51549809-568AA2BD-C4F1-449F-AF73-99CBCC6BD6CBQ57073785-74EE5E91-0337-4C41-8936-38285F022F34Q58701464-FBE90378-E7CE-4F4E-8188-232279028FD5
P2860
The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The prognostic role of ERG imm ...... and review of the literature.
@en
type
label
The prognostic role of ERG imm ...... and review of the literature.
@en
prefLabel
The prognostic role of ERG imm ...... and review of the literature.
@en
P2093
P1433
P1476
The prognostic role of ERG imm ...... and review of the literature.
@en
P2093
Alice Dragomir
Armen Aprikian
Eleanora Scarlata
Fadi Brimo
Myriam Chevarie-Davis
Nebras Zeizafoun
Simon Tanguay
Simone Chevalier
Wassim Kassouf
P304
P356
10.1016/J.HUMPATH.2013.10.012
P407
P50
P577
2013-10-23T00:00:00Z